ورود دانشجویان

سیاست گذاری در دارو - مدیریت زنجیره تامین - اخلاق حرفه ای در کسب و کارهای دارویی

 

ABBAS KEBRIAEEZADEH

Date of Birth; 22 May 1966

Present position:

Professor

Faculty of Pharmacy

TEHRAN UNIVERSITY OF MEDICAL SCIENCES,

TEHRAN, P.O.Box 14155/6451; I.R.IRANE mail: kebriaee@sina.tums.ac.ir

kebriaee@osvahpharma.com

 

Qualifications;

Pharm.D.

UNIVERSITY OF TEHRAN 1991

                             Ph.D

Department of pharmacology,  Shahid Beheshti University of Medical Sciences (1996).

Scholarships and awards

1-International Brain Research organization (IBRO) Postdoctoral workshop (6-25 April 1994) Chinese university of Hong Kong

2- Short course; Adapting Disease Specific Quality of Life Measurement for Utility Measurement,  3 November 2002 at the ISPOR Fifth Annual European congress ,

Rotterdam, The Netherlands, 3-5 November2002.

 3- Short course; Pharmacoeconomic Evaluation: Methods and Applications for Decision Making,  2 November 2002 at the ISPOR Fifth Annual European congress ,

Rotterdam, The Netherlands, 3-5 November2002.

                              Position Held

 

2014- 2017  chairman of Board of Director, Social Security Organization, Iran

2007 -  Now   Professor of  pharmacology , Department of Toxicology  & pharmacology , the head of department of  pharmacoeconomics  and pharmaceutical management,  faculty of pharmacy, TEHRAN UNIVERSITY OF MEDICAL SCIENCES , Tehran, Iran.

 

2004- Now The head of pharmaceutical sciences research network, ministry of health, IRAN

2015 – Now president of pharmacoeconomics and pharmaceutical research center, Tehran University of Medical Sciences, Tehran, Iran.

2014- 2015    president, Alhavi pharmaceutical co., Tehran, Iran

2012-2014    Director General of Alhavi pharmaceutical co., Tehran, Iran

2005 – 2012   Director general, Osvah pharmaceutical Co., Tehran, Iran

2004 – 2007    Manager of pharmaceutical  incubator center, Tehran University of Medical Sciences.

2002 -  2007   Associate professor in pharmacology , Department of Toxicology  & pharmacology , faculty of pharmacy, TEHRAN UNIVERSITY OF MEDICAL SCIENCES.

1999 – 2003  Director General ,  Pharmaceutical Division of MOH.

1996 -  2002-  Assistant professor in pharmacology,Department of Toxicol & pharmacol , TEHRAN UNIVERSITY OF MEDICAL SCIENCES,and Deputy of education, faculty of pharmacy.

1991-1996    Ph.D. student in department  of Pharmacology and lecturer in faculty of pharmacy, Tehran University of Medical Sciences, Tehran, IRAN

  1. Pharmacy student in Faculty of Pharmacy, UNIVERSITY OF THERAN,I.R.IRAN.

 

                                 Papers

 

1.Shafiee  A.,Cheraghali A.M.,Kebriyaeezadeh A.(1988) sepectrophotometry and gas chromatography of mustards; Med. J. I.R. IRAN , vol. 2, Nos 3, 213-218.

 

2. Abdollahi M., Jafari A., Jalali N., Balali -Mood M., Kebriyaeezadeh A., Nikfar S., (1995) A new approch to the effficacy of oximes in the management of acute organophosphate poisoning; Iranian J. Med. Sci vol. 20 , nos 3-4, 105-109.

 

3. Abdollahi M., Balali-Mood M., akhgari M., Jannat B., kebriyaeezadeh A. Nikfar S.,(1996) A survey of cholinestrase activity in healty and organophosphate expoused populations. Iranian J. Med .Sci. vol. 21, nos 1-2, 63-68.

 

4. kebriyaeezadeh A., (1992) Angiotensin and angiotensin converting enzyme inhibitors (article reveiw). Razi,vol9,6-17. (persian Language) .

 

5. Kebriyaeezadeh A. (1994) The nasal decongestants (article review)Razi,vol.12,11-16,(persian Language).

 

6. kebriyaeezadeh A., (1994) Pharmacokinetic of valproic acid. Razi,vol9,10-15.

 

7. Kebriyaeezadeh A. (1995) Species differences in response to drugs. Razi vol 9,21-26   (Persian Language).

 

8.  Kebriyaeezadeh A., Sharifzadeh M., Soltaninejad K., (1998) Investigation of PTU-induced hypothyroidism on PTZ induced kindling parameters in chronic lead  intoxicated rats. Med.J. of I.R.IRAN 12 ( 2): 141-146.

 

9. Sharifzadeh M.,Abdollahi M.,Kebriyaeezadeh A., Dehpour A.R., Mohammad M., (1997)Altrations of physostigmine-induced yawning by chronic lithium in rats

 

10. Kebriyaeezadeh A.,Abdollahi M.,Sharifzadeh M.,Baradaran M.,(1997) Lead levels in the inhabitants of tehran city districts. Pejouhandeh vol.2,no.2,67-72.

 

11.Sh.Nickfar,M.Abdollahi,A.Kebriyaeezadeh,M.chitsaz;(1997)Effect of granisetron on morphin induced analgesia in mice by formalin test.Gen Pharmacol vol31,no1,55-58.

 

12. Kebriyaeezadeh A. Valae, M., and A.Zarghi; (1998) Determination of valporic acid in human plasma by gas chromatography. Pharm Phamacol Commun 4: 525-527.

 

13. G. Behzadian-nejad, A. Rezaee, A. Kebriyaeezadeh, and R. Ahmadkaniha; (1998) High performance liquid chromatographic determination of trimetoprime in mouse liver, Pharm Pharmacol Commun 4: 439-441.

 

14. A. kebriyaezadeh A., Mazaheri F., Abdollahi M., The protective effects of SP antagonists on ophthalmic effects of Nitrogen mustard; Kosar of Med. Journal, spring, 1999; PP: 49-54.

 

15. Kebriyaeezadeh A. , A. Zarghi, R. Ahmadkhaniha, A. Khoddam and A.J. Ebrahimian,. (2000), Simultaneous High performance liquid Chromatographic determination of sulphamethoxazole and trimethoprim in the plasma of man,Pharm.Pharmacol. Comman.,vol.4,439-441.

 

16. Kebriyaeezadeh A. , Parvar Gh. Parinegad S., Taghipour M. (2000) Statistical evaluation of drug uses in IRAN, in 1378 (1999 – 2000). Razi, No. 6; 55-61.

 

17. Ostad S.N.,Kebriaeezadeh A.,Zarekamali R., Abdollahi M., Marzban , Akhgari (2001) The protective effect of  indomethacine on HP-induced ocular damage in the eye, Med J.I.R. of Iran 14(4);385-391.

 

 18. Zarghi A., Kebriaeezadeh A., Ahmadkaniha A.R., (2001) Rapid high performance of liquid chromatographic method for determination of doxycycline in human plsma,Boll. Chim. farmac. 140(2);112-114.

 

19. Kebriaeezadeh A., Masiha Akbar R., Soltaninejad K., (2001) Alteration of PTZ- induced kindling parameters by prenatal lead exposure ia rats.Daru;9(3-4);24-27.

 

20. Ghane T., Kebriaeezadeh A., Ostad S.N., Dehpour A.R.(2001) The effect of lead acetate on the NO system in the rat hypocampal cells an invitro study. Acta Medica Iranica;9(1);57-62.

 

21.Kebriaeezadeh A.,Inanlo H.R.,(2001) critsfield jakob disease;Razi,12,39-43.

 

22. Kebriaeezadeh A.,Habibi F.,Samiee M.,Parvar G.R.;(2001) Statistical reports on drug uses in Iran in period of april2000-april2001,( 2001);Razi,9;46-55.

 

23. Kebriaeezadeh A. Statistical reports on drug uses of central nervous agents in duration of april2000-april2001 in Iran;Iranian journal of neurology,1(2-3);1-2.

 

24.Khalaj A.,Abdollahi M.,Kebriaeezadeh A.,Adibpour N.,Pandi Z.,Rasoulamini S.,(2002) The antiniciceptive and anti-inflammatory activities and lack of ulcerogenicity of a benzodioxine-4-one and its analog benzoxazine as cyclic acetal like derivatives of salicylic acid and salycylamide in mice and rats,Indian journal of pharmacology,34

 

25. Kebriaeezadeh A.,Mirahmadi N.,(2002) The regulations of drug distribution in France,Italy and  Germany ;Razi,147;55-69.

 

26. Kebriaeezadeh A.,Inanlou H.R.; (2002) The cardiotoxic and neurotoxic effect of first generation of antihistamines; Razi,vol4,141-145.

 

   27. Zarghi A.,Kebriaeezadeh A.,Ahmadkhaniha R.,Rastkari N.,(2001) Selective liquid chromatographic method for determination of fluoxetine in plasma, J. AOAC intern. Vol84(6),1-3.

 

28. Kebriaeezadeh A.,Abdollahi-Asl A., Razavi S.A.M., (2002) The Economical Sitiation of  Pharmacies in Iran; Razi 11;62-70.

 

29. Akhgari M., Abdollahi M., Kebriaeezadeh A., Hosseni R., Sabzevari O.,(2003) Biochemical Evidence for Free Radical-Induced Lipid Peroxidation as a Mechanism for Subchronic Toxicity of Malathion in Blood and Liver of Rats. Human & Experimental Toxicology; 22:205 – 211.

 

30. Kazemifard A.G., Moore D.E., Mohammadi A., Kebriaeezadeh A., (2003) Capillary Gas Chromatography Determination of Benzaldehyde  Arising from Benzyl Alcohol Used as Preservative in Injectable Formulations. Journal of Pharmaceutical and Biomedical Analysis; 31: 685 – 691.

 

31. Soltaninejad K.,Kebriaeezadeh A., Minaee B.,Ostad S.N., Hosseini R., Azizi E., Abdollahi M.,(2003) Biochemical and ultrastructural evidences for toxicity of lead through free radicals in rat brain. Human & Experimental  Toxicology 22:417-423.

 

32. Miri R.,Javidnia K., Kebriaie-zadeh A., Niknahad H., Shaygani N., Semnanian S., Shafiee A.,(2003) Synthesis and evaluation of pharmacological activities 3,5-dialkyl 1,4-dihydro – 2,6- dimethyl-4-nitroimidazole 3,5-pyridine dicarboxylates. Arch.Pharm.Pharm.Med.Chem;336:422-428.

 

33-   Abbas Kebriaee-zadeh;  Overview of National Drug Policy of Iran, Iranian Journal of Pharmaceutical Research (2003) I-II

 

 

34 . A.Almasirad, Sayyed A. Tabatabai, M. Faizi, A. Kebriaeezadeh, N. Mehrabi, A. Dalvandi, A. Shafiee (2004); Synthesis and Anticonvulsant Activity of New 2-Substituted-5-[2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-Triazoles; Bioorganic & medical chemistry letter 14: 6057-6059.

 

35. Sh. Rezazadeh, A. Kebryaeezadeh, M. Pirali-Hamedani, A. Shafiee,  S. Gharuni Isfahani;( 2005) Anti-inflammatory and analgesic activity of methanolic extracts of aerial parts of Stachys schtschegleevii Sosn. and Stachys balansae Boiss. & Kotschy ex Boiss in rats; Daru  13(4), 165-169.

36. S. Karkheiran, A. Kebriaeezadeh, H. Pakdaman, K. Soltaninejad (2005); Valeriana Officinalis total extract as adjunctive therapy in patients withrefractory symptomatic generalized epilepsy; Iranian Journal of Neurology 3(9); 51-65.

 37. S. Nikfar, A. Kebriaeezadeh, R. Majdzadeh, M. Abdollahi (2005); Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran; BMC International  and Human Rights; 5: 1-15.

 38. V. Ziaee, E.Akbari Hamed, A.Hoshmand, H. Amini, A. Kebriaeezadeh, K. Saman (2005); Side effects of dextrometorphan abuse, a case series; Addictive Bahaviors, 30, 1607-1613.

39. S. Emami, A. Kebriaeezadeh, M. J. Zamani, A. Shafiee;(2006): azolylchromans as a novel scaffold for anticonvulsant activity; Bioorganic & medical chemistry letter16; 1803-1806.

 

40. S.N.Ostad, M. Sharifzadeh, E. Azizi, A. Kebriaeezadeh; (2006) Lead exposure impairs NMDA agonist- induced NO production in pyramidal hippocampal cells; DARU 14(1); 44-50.

41. N.Hashemi, A. Mohammadirad, Z. Bayrami, R. Khorasani, S. Vosough, A. Aliahmad, Sh. Nikfar, M. Sharifzadeh, A. Kebriaeezadeh, and M. abdollahi (2006); Restoration of morphin- induced alteration in rat submandibular gland function by N-methyl-D-aspartate agonist ,Acta Biologica Hungarica; 57(3); 283-294.

 

42. E.Souri,H.Jalalizadeh, A. Kebriaee zadeh, M. Shekarchi, and A. Dalvandi (2006); Validated HPLC method for determination of carboxylic acid metabolite of clopidogrel in human plasma and its application to a pharmacokinetic study. Biomed. Chromatogr 20: 1309- 1314.

43. E. Souri, H. Jalalizadeh, A. Kebriaee zadeh, and B. Zadehvakili, (2007); HPLC analysis of orlistat and its application to drug quality control studies. Chem. Pharm. Bull.55(2),

44.M.Hadipour Dehshal , A.H. Hooghooghi , A. Kebriaeezadeh, M. Kheirabadi, Sh. Kazemi, A. Nasseh, A. Shariftabrizi, P. Pasalar (2007); Zinc deficiency aggravates abnormal glucose metabolism in thalassemia major patients; Med Sci. Monit, 13(5):CR235-239.

45. Ali Almasirad,Nasim Vousooghi, Sayyed Abbas Tabatabai, Abbas Kebriaeezadeh and Abbas Shafiee ( 2007); Synthesis, Anticonvulsant and Muscle relaxant activities of Substituted 1,3-,4- oxadiazole, 1,3, 4- thiadiazole and 1,2,4- triazole; Acta Chim Slov,54, 317 – 324.

46. Reza Ahmadkhanihaa, Noushin Rastkarib, Farzad Kobarfardc, 

Hossein Pakdamand, Omid Ahmadkhanihae, Abbas Kebriaeezadehf,; (2008)

An Improved GC Method for Rapid Analysis of Valproic Acid

in Human Plasma without Derivatization; IJPS; October 2008; 37-41.

 

47. Abbas Kebriaeezadeh, Saeed Emami,Mohsen Ebrahimi ,

Mohammad Sharifzadeha, Reza Khorasani, Abbas Shafiee;(2008); Anticonvulsant and antiepileptogenic effects of azolylchromanones on lithiumepilocarpine induced seizures and pentylenetetrazole-kindling model of epilepsy; Biomedicine et Pharmacotherapy

; Vol 62/4(2008) pp 208-211.

 

48. Reza Afshar, Suzan Sanavi, Abbas Kebryaeezadeh, Mohsen Naiebpoor, Mahboob Lesanpezeshki, Mohammad-Reza Khatami, Effat Razeghi;(2008)Hemoglobin and Hematocrit Rise in End-Stage Renal Disease (ESRD) with PDpoetin: Results of a Phase ?, Multicenter Clinical Trial; Iranian journal of pathology;3;157-60.

 

49-  H.Vatandoos,A.Khazani, J. Rafinejad, M. Khobde, A Kebriai Zadeh, MR Abtahi;(2008) comparative efficacy of neem and dimethylphthalate (DMP) againt malaria vector, Anopheles stephensi(dip-tera;culicidae); Asian pac J trop med,1(3), 1-6.

 

50- Hussein Rayatzadeh a, Mohsen Nouri a,b, Mehdi Ghasemi a, Abbas

Kebriaeezadeh , Shahram Ejtemaei Mehr a, Ahmad Reza Dehpour;

(2009)Effect of metal chelating agents on pentylenetetrazoleinduced

seizure threshold in cholestatic mice; Seizure . 18; 51-56.

51- Seyed Vahid Shetab Boushehri1, Maryam Tamimi2, and Abbas Kebriaeezadeh 2, Quantitative determination of 3,4- methylenedioxymethamphetamine by thin- layer chromatography in ecstasy illicit Pills in Tehran , Toxicology Mechanisms and Methods,2009,19(9):565-569

52- SH.Rezazadeh1,J.Zaringhalam2*,H.Manaheji2,A. Kebryaeezadeh3- Anti-inflammatory and anti-hyperalgesic activities of Stachys athorecalyx extracts on CFA- induced inflammation- Journal of Medicinal Plants Research Vol.3(5),pp. 368-376,May,2009

53- Abbas Shafiee, Ardeshir Rineh, Abbas Kebriaeezadeh, Alireza Foroumadi, Vahid Sheibani and Mohammad Reza Afarinesh;  (2009) Synthesis and anticonvulsant activity of 4-(2-phenoxyphenyl)semicarbazones ;Medicinal chemistry research;18(9);758-769.

 

54-  S.J. Hosseinimehr, D. Beiki, A. Kebriaeezadeh, A. Khalaj, M. Pirali Hamedani, S. Akhlaghpoor, H. Esmaeili, A.R. Barazesh,Synthesis and radioprotective study of novel amino-alkyldithiocarbamic acid derivatives against γ-irradiation in mice.Iran. J. Radiat. Res., 2009; 7 (2): 91-96

.  

 55- MASSOUD AMANLOU*, MOHADESEH ZAREI-GHOBADI,MOHAMMAD KAZEM ROFOUEI,SHAHROOZ SAREMI and ABBAS KEBRIAEEZADEH , Extractive Spectrophotometric method for Determination of Pioglitazone Hydrochloride in Raw Material and Tablets Using Ion- Pair Formation- E-Journal of Chemistry 2010,7(3),915-921

56- Saeed Emamia,*, Abbas Kebriaeezadehb,Nematollah Ahangarc,Reza Khorasanib, Imidazolylchromanone Oxime ethers as Potential anticonvulsant agents: Anticonvlsive evaluation in PTZ- Kindling model of epilepsy and SAR Study, Bioorganic&Medicinal Chemistry Letters xxx (2010)xxx-xxx

57- N.Amini-Shirazi,2R. Ahmadkhaniha, 3.5S. Shadnia,1M.H. Ghahremani,M. Abdollahi,2A. Dadgar and A.Kebriaeezadeh,   Determination of VPA and its Two Important Metabolites in Iranian Overdosed Patients , International Journal of Pharmacology,2010 IssN 1811-7775; 6(6); 854-862.

58-  Noushin Amini-Shirazi1,2,Mohammad Hossein Ghahremani1,Reza Ahmadkhaniha3,Ali Mandegary4,Armin Dadgar3,Mohammad Abdollahi1,Shahin Shadnia5,6,Hossein Pakdaman6,and Abbas Kebriaeezadeh1 - Influence of CYp2C9 Polymorphism on metabolism of valproate and its hepatotoxin metabolite in Iranian Patients,Toxicology Mechanisms and Methods ,2010,20(8): 452-457

59- Rezaei Mokarram A., 2Kebriaee Zadeh A.,3Keshavarz M.,3Ahmadi A.,3Mohtat B., Preparation and in- Vitro evaluation of indomethacin nanoparticles, DARU Vol. 18,No.3 2010; 185-192.

60- Seyed Vahid Shetab Boushehri1,Seyed Nasser Ostad1,Saeed Sarkar2,Dmitry A.Kuznetsov3,Anatoly L. Buchachenko4,Marian A.Orlova,Bagher Minaii5,Abbas Kebriaeezadeh1,and Seyed Mahdi Rezayat6. The C60-Fullerene Porphyrin Adducts for Prevention of the Doxorubicin- Induced Acute Cardiotoxicity in Rat Myocardial Cells; Acta Medica Iranica; (2010); 48(5); 342-350.

 

61- Saeed Emami , Abbas Kebriaeezadeh , Nematollah Ahangar , Reza Khorasani

Imidazolylchromanone oxime ethers as potential anticonvulsant agents:

Anticonvulsive evaluation in PTZ-kindling model of epilepsy and SAR study; Bioorganic and Medicinal Chemistry Letters (2011); 21;655-659.

 

62. Akbar Abdollahiasl, Abbas Kebriaeezadeh, Shekoufeh Nikfar, Amir Farshchi, Golbarg Ghiasi, Mohammad Abdollahi; Patterns of antibiotic consumption in Iran during 2000-2009; International journal of antimicrobial agents;37( 2011); 489-490.

 

63. Kian Azami, Kaveh Tabrizian, Rohollah Hosseini, Mohammad Seyedabadi, Marjan Shariatpanahi, Farshid Noorbakhsh, Abbas Kebriaeezadeh, Seyed Nasser Ostad, Mohammad Sharifzadeh; Nicotine attenuates spatial learning deficits induced by sodium metavanadate; Neurotoxicology; 33(2012); 44-52.

 

64. M.Abdollahi*,M.Baradaran,M.Etebari,T.Ghanea,Gh.Karimi, A.Kebriaeezadeh,Sh.Nikfar,M.Rahgozar,M.Saberi; 2012 ANNUALREPORTOFTEHRANDRUG&POISON INFORMATIONCENTERIN1997;

Human toxicology;

 

65.KhosroKeshavarz,AbbasKebriaeezadeh,AmirHashemiMeshkini, ShekoufehNikfar,ImanMirian and HasanKhoonsari ; Financialperspectiveofprivatepharmaciesin3Tehran(Iran);isitalucrativebusiness?

DARUJournalofPharmaceuticalSciences2012,20:62.

66. KebriaeeA, RasdidianA, GhiasiG, SalamzadehJ, DorkooshFA; AVAILABILITY,AFFORDABILITYANDPRICEOFASTHMAMEDICINESIN TEHRAN;IRAN; VALUEINHEALTH15(2012)A277–A575.

 

67. Shervin Taslimia, Alireza Esteghamatia,∗, Armin Rashidib, Hosein Moin Tavakkolia,Manouchehr Nakhjavania, Abbas Kebriaee-Zadeh; Treatment with pioglitazone is associated with decreased preprandial ghrelinlevels: A randomized clinical  trial ; peptides ; 40(2013);89-92.

 

68. ZahraGharibnaseri,AbbasKebriaeezadeh, ShekoufehNikfar1, GholamrezaZamani, andAkbarAbdollahias ; Cost-effectivenessofadding-onnewantiepileptic drugstoconventionalregimensincontrolling intractableseizuresinchildren ; DARUJournal of Pharmaceutical Sciences2012,20:17.

 

69. AmirHashemiMeshkini, AbbasKebriaeezadeh, RasoulDinarvand, ShekoufehNikfar,  MohammadGafarHabibzadeh, and ImanVazirian; AssessmentofthevaccineindustryinIranin contextofaccessiontoWTO:asurveystudy . DARUJournal of Pharmaceutical Sciences 2012,20:19.

 

70. HosseinMirmiranpoura, S.ZahraBathaieb,⁎, ShahnazKhaghania, ManouchehrNakhjavanic, AbbasKebriaeezadeh ; Investigationofthemechanism(s)involvedindecreasingincreasedfibrinogen activityinhyperglycemicconditionsusingL-lysinesupplementation; 

Thrombosis research; 2012;

 

71. AmirHashemi-Meshkini, KhosroKeshavarz, ZahraGharibnaseri, MehrnazKheirandish,  Abbas Kebriaeezadeh, Shekoufeh Nikfar, Mohammad Abdollahi; Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer; Arch Med Sci; 2013;

 

72. Amir Hashemi-Meshkinia, Khosro Keshavarza, Shekoufeh Nikfara,b, Iman Vazirianc and Abbas Kebriaeezadeh; Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study ; Iranian Journal of Pharmaceutical Research (2013), 12 (4): 953-962.

 

73. Saman Zartab, S. Farshad Fatemi, Abbas Kebriaee-zadeh, Ramin Radmanesh; Fundamentals and Stock Return in Pharmaceutical Companies: a Panel Data Model of Iranian Industry ; Iranian Journal of Pharmaceutical Sciences Winter 2013: 9(1): 114-170.

 

74. AbbasKebriaeezadeh, NasserNassiriKoopaei, AkbarAbdollahiasl1, ShekoufehNikfar, and NafisehMohamadi;  Trend analysis of the pharmaceutical market in Iran;1997–2010; policy implications for developing countries ; DARUJournal of Pharmaceutical Sciences 2013,21:52.

 

75. ShekoufehNikfar , AbbasKebriaeezadeh, RassoulDinarvand, MohammadAbdollahi, Mohammad-Ali Sahraian,  David Henry, and Ali Akbari Sari; Cost-effectivenessofdifferentinterferonbeta productsforrelapsing-remittingandsecondary progressivemultiplesclerosis:Decisionanalysis basedonlong-termclinicaldataandswitchable treatments ; DARU Journal of Pharmaceutical Sciences2013,21:50.

 

76. Khosro Keshavarz1, Amir Hashemi-Meshkini, Zahra Gharibnaseri, Shekoufeh Nikfar,  Abbas Kebriaeezadeh, Mohammad Abdollahi;  A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience ; Arch Med Sci 2013; 9, 6: 961–967.

 

77 . Shahrooz Saremi, RassoulDinarvand, AbbasKebriaeezadeh,  Seyed Nasser Ostad, and Fatemeh Atyabi1, ; Enhanced Oral Delivery of Docetaxel Using Thiolated Chitosan Nanoparticles: Preparation, In Vitro and In Vivo Studies ; BioMed Research International; 2013 .

 

78. Hamid Irannejada, Abbas Kebriaieezadehb, Afshin Zarghi, Farhad Montazer-Sadeghb, AbbasShafiee, Amir Assadi eskandar, MohsenAmini ; Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1,2,4-triazine as selective cyclooxygenase-2inhibitors ; Bioorg. Med. Chem.22(2014)865–873.

 

79. Mohammad Ali Rezvanfar,  Abbas Kebriaeezadeh,  Mostafa Moein,  Shekoufeh Nikfar,  Zahra Gharibnaseri,  Akbar Abdollahi-Asl. Cost analysis of childhood asthma in Iran:  A cost evaluation based on referral center data for asthma and allergies ; Journal of Research in Pharmacy Practice  /  Oct-Dec 2013  /  Vol 2  /  Issue 4; 162-168.

 

80. Amir Hashemi Meshkini , Abbas Kebriaeezadeh ,  Mohammad Reza Janghorban ,  Khosro Keshavarz 1, Shekoufeh Nikfar ; Assessment of Geographic Accessibility to Pharmacy in Qom, Iran: A Geographic Information System Analysis ; Thrita. 2014;3(1):e9648; 1-6.

 

81 Nasser Nassiri-Koopaei,  RezaMajdzadeh, AbbasKebriaeezadeh, ArashRashidian, MojtabaTabatabai Yazdi,  Saharnaz Nedjat, and Shekoufeh Nikfar. Commercializationofbiopharmaceutical knowledgeinIran;challengesandsolutions ; DARU Journal of Pharmaceutical Sciences ; 2014,22:29.

 

82- Ali-Akbar Golabchifar, Saeed Rezaee, Nahid Mobarghei Dinan,  Abbas Kebriaeezadeh, Mohammad-Reza Rouini, Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers; Eur J Drug Metab Pharmacokinet; july 2015.

 

83- Hossein Mirmiranpour, Shahnaz Khaghani, S. Zahra Bathaie, Manouchehr Nakhjavani,  Abbas Kebriaeezadeh, Maryam Ebadi, Siavash Gerayesh-Nejad , and Mohammad  Zangooei; The Preventive Effect of L-Lysine on Lysozyme Glycation in Type 2 Diabetes; Acta Medica Iranica, Vol. 54, No. 1 (2016);24-31.

 

84-Jaberidoost MOlfat LHosseini A, Kebriaeezadeh AAbdollahi MAlaeddini MDinarvand R; Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods; J Pharm Policy Pract. 2015 Feb 28;8(1):, .2-10.

 

85- Amirreza Hosseinzadeh1, Alireza Yektadoost1, Hamidreza Hozouri2, Rassoul Dinarvand3, Abbas Kebriaeezadeh; Quality Assurance Status in Iranian Pharmaceutical Industry: A Survey: Journal of Pharmacoeconomics and Pharmaceutical Management 2014; 1(1): 14-21.

 

86-  Mehrnaz Kheirandish, Zahra Gharibnaseri, Fatemeh Soleymani, Abbas Kebriaeezadeh; Prior authorization by the Health Insurance Organizations in Iran ; Journal of Pharmacoeconomics and Pharmaceutical Management 2015; 1(2): 59-60.

 

87- Zahra Gharibnasri, Mehrnaz Kheirandis, Bahram Delfan,  Abbas Kebriaeezadeh; Geographical distribution of pharmacies in two provincial capitals in Iran; Journal of Pharmacoeconomics and Pharmaceutical Management 2015; 1(2): 53-55.

 

88- Mehrnaz Kheirandish, Arash Rashidian, Abbas Kebriaeezade, Abdol Majid Cheraghali,  Fatemeh Soleymani; A review of pharmaceutical policies in response to economic crises and sanctions; Journal of Research in Pharmacy Practice  /  Jul-Sep 2015  /  Vol 4  /  Issue3.

 

89 - Nima Tahmasebi and Abbas Kebriaeezadeh; Evaluation of Factors Affecting Prescribing Behaviors, in Iran Pharmaceutical Market by Econometric Methods; Iranian Journal of Pharmaceutical Research (2015), 14 (2):

 

90- Akbar Abdollahiasl,Abbas Kebriaeezadeh,Rassoul Dinarvand, Mohammad Abdollahi, Abdol Majid Cheraghali , Mona Jaberidoost, Shekoufeh Nikfar; A system dynamics model for national drug policy; Daru. 2014; 22(1): 34. 2-13..

 

91- Farshchi A, Esteghamati A, Sari AA, Kebriaeezadeh A, Abdollahi M, Dorkoosh FA, Khamseh ME, Aghili R, Keshtkar A, Ebadi M; The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus; Journal of Diabetes & Metabolic Disorders 2014, 13:42; 2-14.

 

92- Amir Farshchi, Abbas Kebriaeezadeh* and Rassoul Dinarvand; Annual Pharma Statistics” as a Health Information System Application in Iranian Pharmaceutical Sector; Iranian Journal of Pharmaceutical Research (2015), 14 (1): 1-3.

 

93- A. Kebriaeezadeh, S.N. Marashi Shushtari, Sh. Ghodsi; Priority Setting for Productivity Indices in Iranian Pharmaceutical Companies; Journal of Pharmacoeconomics and Pharmaceutical Management 2014; 1(1): 26-30.

 

94- Khosro Keshavarz, Amir Hashemi Meshkini, Pardis Zaboli, Jamal Khedmati, Abbas Kebriaeezadeh; Drug Eluting Balloon: An Overview of Clinical Evidences on Safety and Effectiveness; Journal of Pharmacoeconomics and Pharmaceutical Management 2014; 1(1): 6-8.

 

95- Khosro Keshavarz; Abbas Kebriaeezadeh ; Seyed Moayed Alavian ; Ali Akbari Sari; Farid Abedin Dorkoosh; Maryam Keshvari ; Seyed Ali Malekhosseini ; Saman Nikeghbalian ; Shekoufeh Nikfar;  Economic Burden of Hepatitis B Virus-Related Diseases: Evidence From Iran;   Hepat Mon. 2015 April; 15(4) ; 1-9.

 

96- Shekoufeh Nikfar, Zaheer-Ud-Din Babar, Rassoul Dinarvand, Abbas Kebriaeezadeh, and Mohammad Abdollahi; Consistent defined threshold and equity in health; DARU journal of pharmaceutical sciences;  2015; 23(1): 12.

 

97- Amir Hashemi-Meshkini1,2, Mehdi Varmaghani1,2, Mehdi Yousefi3, Saeed Yaghoubifard1, Hedieh-Sadat Zekri4, Shekoufeh Nikfar1,5, Abbas Kebriaeezadeh; From generic scheme to brand‑generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?; Journal of Research in Pharmacy Practice  /  Jul-Sep 2014  /  Vol 3  /  Issue3; 88-93.

 

98-  Khosro Keshavarz, Amir Hashemi-Meshkini, Pardis Zaboli, Jamal Khedmati, Abbas Kebriaeezadeh; Drug-Eluting Balloon: An Overview of Clinical Evidences on Safety and Effectiveness ; Journal of Pharmacoeconomics and Pharmaceutical Management 2014; 1(1): 6-9.

 

 99- Mehdi Varmaghani, Amir Hashemi Meshkini,  Farshad Farzadfar, Mehdi Yousefi , Saeed Yaghoubifard, Vida Varahrami,  Ehsan Rezaei Darzi, Majid Anabi, Abbas Kebriaeezadeh; Evaluation of productivity in Iranian pharmaceutical companies: A data envelopment analysis-based Malmquist approach and panel data analysis; Journal of Research in Pharmacy Practice  /  Apr-Jun 2015  /  Vol 4  /  Issue2; 1-6.

100- Mehdi Varmaghani, Farshad Farzadfar, Farshad Sharifi, Arash Rashidain, Mostafa Moin,  Maziar Moradi-Lakeh, Shadi Rahimzadeh, Sahar Saeedi Moghaddam, and Abbas Kebriaeezadeh; Prevalence of Asthma, COPD, and Chronic Bronchitis in Iran:  A Systematic Review and Meta-analysis; Iran J Allergy Asthma Immunol 2016  In press.

 

 

 

 

 

 

I published 8 books in pharmacology, toxicology, and pharmaceutical management field

کتابهای چاپ شده                                                                                                     1- نگرشی بر نظام دارویی ایران سال 1380

2- مجموعه قوانین دارویی ایران  چاپ اول 1382 و چاپ دوم 1387

3- آسم و آلرژی در ایران ( یک فصل از کتاب1382 )

4- سم شناسی (1386) دو فصل از کتاب

5- مقدمه ای بر فارماکواپیدمیولوژی 1388

6- گواهیهای کیفیت در صنعت داروسازی ( راهنمای صادرات دارو)1390

7- مدیریت در داروسازی 1392

8- نگرشی کاربردی بر سیاستگزاری نظام دارویی 1394 ( ترجمه زیر نظر اینجانب )

 

 

 

 

 

 

Abstracts;

 

1. Shafiee A., Kebriyaeezadeh A., Tajerzadeh H., (1991) The renal Excretion kinetic of mustard gas in rabbit. 3rd Iranian Pharmaceutial congress ; (Ahwas).

2. Kebriyaeezadeh A., Mazheri F., (1993) The protective effect of  substance-P antagonist on opthalmic effect of mustards, 3rd Iranian congress on poisoning (Mashad) and  XII international congress of pharmacology (Canada).

3. Kebriyaeezadeh A., Ebrahimi S., (1995) The evaluation of convulsive effects of pilocarpine in pre and postnatal chronic Lead intoxication in mice 4th Iranian congress on poisoning (Tehran).

4. Kebriyaeezadeh A., Khademorreza N., (1995) The evalution of convulsive effects of strychnine in pre and postnatal chronic Lead intoxication in mice. 4th Iranian congress on poisoning (Tehran).

5. Sharifzadeh M., kebriyaeezadeh A., Dehpour A.R., Gholipour F., (1995) Effect of chronic lead treatment on theophylline-induced grooming in rats. 4th Iranian congress on poisoning(Tehran).

6. Yasa N., Kebriyaeezadeh A., Ghorbani S., (1995) study of analgesic effect of zataria multiflora (Labiatae) in rat. XII international congress of physiology and Pharmacology (Tehran).

7. Kebriyaeezadeh A., Pourgholami M.H., Shafiee A., Miri R., (1995) Anticonvulsant activity of some dihydropyridine derivatives in amygdala kindled rats. XII international congress of physiology and pharmacology (Tehran).

8. Kebriyaeezadeh A., Pourgholamin M.H., (1995) Involvement of serotonergic systems in anticonvulsant activity of valproic acid in amygdala kindled rats. XII international congresss of physiology and pharmacology (Tehran).

9. abdollahi M., Kebriyaeezadeh A., pirdehghan F., Jannat B., Jalali N. (1995) Cholinestrase activity in saliva, plasma and erythrocyte of the Iranian population. Tox. Let. Suppl. 1, Page 1.

10. Kebriyaeezadeh A., Jannat B., Jalalizadeh H., Khorasani R., (1996) The risk expouse population in clinical study of drugs. First Iranian congress on etichs in pharmacy (Tehran).

11. abdollahi M., Kebriyaeezadeh A., Amini G., Jannat B., (1996) Cadminum expousure during gestation increases Two-way avoidance in dams. 1st Iranian congress of Neuroscience (Tehran).

12. Kebriyaeezadeh A., Masiha - Akbar R., (1996) The effect of prental lead intoxication on PTZ -kindling. 1st Iranian congress of Neuroscience (in press).

13. Kebriyaeezadeh A., Valai N., (1996) Determination of plasma level of valproic acid in some Iranian Patients by gas chromatography. 1st Iranian congress of Neuroscience (Tehran).

14. Kebriyaeezadeh A., vatanpour H., Abdollahi M., Keshavarz M. (1996) The protective effects of capsaicin and indometacin on ocular effect of mustard gas. 1st Iranian congress of Neuroscience (Tehran).

15. Kebriyaeezadeh A , Abdollahi M., Jalali N., Ghanea T (1997) a retrospective study of Poioning in Tehran. Eurotox congress (Denmark).

16. Kebriyaeezadeh A.,Mazaheri F.,Keshavarz M.,(1997)The involvement of chemical mediators:substance-p and prostaglandins in ophthalmic effects of mustards. First international congress of APAMT & fifth iranian congress of toxicology and poisonings(27-30 sept).

17. Kebriyaeezadeh A.,Abdollahi M.,Sharifzadeh M.,Baradaran M.,(1997) Lead; an important health hazard for tehran citizens.

First international congress of APAMT & fifth iranian congress of toxicology and poisonings(27-30 sept).

18. Nikfar S.,Abdollahi M., Kebriyaeezadeh A.,Aghabarati F.,(1997) Effects of aspartame on morphine induced analgesia in mice.First international congress of APAMT & fifth iranian congress of toxicology and poisonings(27-30 sept).

19. Hadjiakhondi A.,Kebriyaeezadeh A.,Mobargha A.,(1997) Anti-inflammatory and analgesic effects of extract and total allkaloids of the ephedra intermedia. First international congress of APAMT & fifth iranian congress of toxicology and poisonings(27-30 sept).

20.M.Abdollahi,M.Baradaran,M. Etebari,T. Ghanea,Gh. Karimi,A. Kebriyaeezadeh,Sh. Nikfar, M. Rahgozar, M.Saberi, M. Sharifzadeh, Annual report of tehran drug & poison information center in 1997.Internationalcongress of toxicology - ICT VIII, July 5-9, 1998.  

21.A.Kebriyaeezadeh,F.mazaheri,M.keshavarz,A.akhgari;The involvement of chemical mediators; substance-p and prostaglandines in ophthalmic effects of mustards.

Internationalcongress of toxicology - ICT VIII, July 5-9, 1998.

22.A.Kebriaeezadeh;Over view of ten years of drug consumption in Iran.8th Iranian Seminar of Pharmaceutical Sciences,Shiraz,Aug,27-29,2002.

  23.Akhgari M., Abdollahi M., Kebriaeezadeh A., Hoseini R., Sabzevari O.; Biochemical evidences for free radical induced lipidperoxidation as a mechanism for sub chronic toxicity of malathion in blood and liver of rats. 8th Iranian Seminar of Pharmaceutical Sciences,Shiraz,Aug,27-29,2002.

24.L.Derakhshan,Z.Motahari,A.Kebriaeezadeh,E.Azizi;Effect of lead acetate on proliferation of T47D and T47D/TAM-R breast cancer cells. 8th Iranian Seminar of Pharmaceutical Sciences,Shiraz,Aug,27-29,2002.

25.K.Soltaninejad,A.Kebriaeezadeh,M.Abdollahi,B.Minaee,S.N.Ostad,Evaluation of biochemical and ultrastructural alteration of free radical mediated toxicity of lead acetate in rat brain. 8th Iranian Seminar of Pharmaceutical Sciences,Shiraz,Aug,27-29,2002.

.

26.A.Kebriaeezadeh,K.Soltaninejad,N.Yasa,F.Ghods;Evaluation of anticonvulsant effects of four medicinal plants extracts on pentylenetetrazole-induced kindling parameters in rats. 8th Iranian Seminar of Pharmaceutical Sciences,Shiraz,Aug,27-29,2002.

27. Kebriaeezadeh A.;(2002) The role of medicinal plants in epilepsy ,Second Iranian congress of neuroscience ; 29 – 31 oct, Tehran Iran.

28. Evaluation  of in vitro release of clonazepam from different vehicles and the effect of enhancers on drug release. Conferences on drug delivery and pharmaceutical technology, Sevilla, Spain;  May 10-12, 2004.

29.  Hashemi M., Sarbolouki M. N., Toliyat T., Kebriaeezadeh A.; Comparison of clonazepam release from dendrosomes with hydrophilic ointment bases in the presence of various enhacers. Drug discovery technology  Europe ; march 9-10, 2004.10.

30. Salamzadeh J., kebriaeezadeh A., shalchi M.; Seasonal drug utilization review of anti-asthma drugs in Iran during the years 2000-2002. 9th seminar of pharmaceutical aciences; Tabriz, Iran ; Aug 23-26 , 2004.10.

31. Salamzadeh J., kebriaeezadeh A., shalchi M.; Drug utilization review of anti-asthma drugs usig defined daily dose (DDD) in 28 provinces of  Iran during the years 2000-2002. 9th seminar of pharmaceutical aciences; Tabriz, Iran ; Aug 23-26 , 2004

32. Kebriaeezadeh A., Overview of national drug policy of Iran based on world health organization criteria. 9th seminar of pharmaceutical aciences; Tabriz, Iran ; Aug 23-26 , 2004

33. Nikfar Sh., Majdzadeh S.R., Kebriaeezadeh A., Abdollahi M., Assesment of the agreement between decisions of drug selecting committee and standardized national drug policy (NDP) indicators9th seminar of pharmaceutical aciences; Tabriz, Iran ; Aug 23-26 , 2004 

34. Kebriaeezadeh A., Overview of chemical warfare agents; Iranian Journal of Pharmaceutical Sciences;3(2);2007;Supplement 1, 9th Iranian Congress of Toxicology; Shiraz, Iran May 15-17, 2007.